Latest Breaking News On - Patented cannabis extraction - Page 1 : comparemela.com

PAO Group, Inc.: PAOG Announces Opportunity To Expand CBD Pharmaceutical Research Sandusky, Ohio (Newsfile Corp. - April 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company s ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled, METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT. Since the acquisition, PAOG engaged Veristat, a contract research organization (CRO), dedicated to the clinical advance of therapies and treatments through regulatory approval. PAOG reports Veristat is making substantial progress in validating and supplementing the underlying research behind RespRx.

United statesKostenloser wertpapierhandelJim diprimaAlkame holdings incAmerican cannabis holdings incResearch fundingGroup incNutraceutical development programDevelopment programSecurities exchangeExtracts incOhio newsfile corpVivo histological research studyChronic obstructive pulmonary disorderNew research funding andInterest in cannabis extraction